0001213900-22-014499.txt : 20220323 0001213900-22-014499.hdr.sgml : 20220323 20220323162916 ACCESSION NUMBER: 0001213900-22-014499 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220321 FILED AS OF DATE: 20220323 DATE AS OF CHANGE: 20220323 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ganjei James Kelly CENTRAL INDEX KEY: 0001767300 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38793 FILM NUMBER: 22763533 MAIL ADDRESS: STREET 1: 10609 RIVER OAKS LANE CITY: POTOMAC STATE: MD ZIP: 20859 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Inmune Bio, Inc. CENTRAL INDEX KEY: 0001711754 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 475205835 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1200 PROSPECT STREET STREET 2: SUITE 525 CITY: LA JOLLA STATE: CA ZIP: 92037 BUSINESS PHONE: 8589643720 MAIL ADDRESS: STREET 1: 1200 PROSPECT STREET STREET 2: SUITE 525 CITY: LA JOLLA STATE: CA ZIP: 92037 4 1 ownership.xml X0306 4 2022-03-21 0 0001711754 Inmune Bio, Inc. INMB 0001767300 Ganjei James Kelly C/O INMUNE BIO INC., 225 NE MIZNER BLVD., SUITE 640 BOCA RATON, FL 33432 1 0 0 0 Common Stock 2022-03-22 4 A 0 17793 8.43 A 17793 D Option (right to buy) 7.92 2022-03-21 4 A 0 35000 0 A 2032-03-20 Common Stock 35000 35000 D The purchase price of the common stock being reported is the closing price per share immediately preceding the entering into of the binding agreement to issue the securities. These shares were purchased by the Reporting Person directly from Issuer. Granted pursuant to the 2021 Stock Incentive Plan. One third (1/3) of the Option will vest at the one-year anniversary of the grant date and the remaining unvested Option will become vested and exercisable 1/24th every month thereafter until the Option is 100% vested which shall occur on the three-year anniversary of the grant date. /s/ James Kelly Ganjei 2022-03-23